Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

AGN-193080, a peripherally acting alpha2-agonist from Allergan

Sep. 20, 1996

Xalatan Solution now available for glaucoma

Sep. 20, 1996

U.S. approval for glaucoma medication

Sep. 13, 1996

Potent antiinflammatory/antioxidant agents from Alcon

Aug. 30, 1996

Study finds latanoprost more effective than timolol

Aug. 30, 1996

Glaucoma diagnostic under investigation in Germany

Aug. 23, 1996

Cannabinoid receptor ligands for glaucoma reported by Merck Frosst

Aug. 16, 1996

Cefazolin/fluoroquinolone combinations show favorable antibacterial activity

July 26, 1996

Fujisawa claims tacrolimus as allergic conjunctivitus treatment

July 26, 1996

Ciclosporin demonstrates efficacy and safety as an antimetabolite

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...